Retatrutide, a novel dual agonist of the GLP-1 receptor and glucose-dependent released polypeptide (GIP) receptor , is demonstrating promising outcomes in preliminary human studies. Current examination https://kingslists.com/story22762486/retatrutide-emerging-research-and-possible-therapeutic-roles